baber/WOPTO huggingface dataset:
Patent AU-2004273852-A1 (AU)
Title: Non-collapsible dual filter element
Inventor: O'HARA CONOR
IPC: B01D29/11
Filed: 2004-09-13
Abstract: An improved liquid filter device comprising a first non-collapsible filter element formed of filter media; a second non-collapsible filter element formed of filter media, the first filter element being operatively contained within the second filter element such that a first space is operatively formed therebetween, the first filter element operatively forming a second space interiorly thereof; an inlet plate, operatively connected at one end of both the first and second filter elements, the inlet plate having an outer circumferential edge and a central area, the second filter element being operatively connected to the inlet plate proximate to the outer edge of the inlet plate, the first filter element being connected to the inlet plate proximate to the central area, the inlet plate operatively communicating with the first space between the first and second filter elements such that the flow of liquid to be filtered is directed into the first space, each filter element being non-collapsible in the axial direction, the inlet plate being operatively positioned to receive liquid to be filtered when the filter element is arranged within a filtration system such that liquid will pass through the inlet plate into the first space between the first and second filter elements for traversing through the filter elements for the filtration thereof. A liquid filter system incorporating the liquid filter element and methods for fabricating the improved liquid filter element are also disclosed.
Patent AU-2004279409-A1 (AU)
Title: Cardiac pacing modality having improved blanking, timing, and therapy delivery methods for extra-systolic stimulation pacing therapy
Inventor: KLEPFER RUTH N
IPC: A61N1/362
Filed: 2004-10-06
Abstract: The present invention relates to the secure delivery of an extra-systolic stimulation (ESS) therapy to treat cardiac dysfunction that employs atrial and/or ventricular extra-systoles via pacing-like stimulation of the heart. These extra-systoles must be timed correctly to achieve beneficial effects on myocardial mechanics (benefit) while maintaining an extremely low level of risk of arrhythmia induction and excellent ICD-like arrhythmia sensing and detection (security). Further experience with ESS has led to improved implementation methods that depend on better blanking, ESS stimulation timing (of an "extra-systolic interval" or ESI), and ESS therapy delivery options and guidance. These methods may be employed individually or in combinations in an external or implantable ESS therapy delivery device.
Patent AU-2004325546-A1 (AU)
Title: Two-stage capping mechanism for inkjet printers
Inventor: SILVERBROOK KIA
IPC: B41J2/165
Filed: 2004-12-06
Abstract: A capping mechanism (21) for a printhead having a capping member (29) which has a length corresponding substantially to the length of the printhead and which is configured to contact the printhead in nozzle capping engagement, and a pivotal carrier (30) supporting the capping member. An actuating mechanism (31) is provided and arranged to effect pivotal movement of the carrier back and forth between a first position at which the capping member is located remotely with respect to the printhead and a second position at which the capping member is located in contact with the printhead. The capping member is pivotally mounted to the carrier and is arranged to pivot relative to the carrier during back and forth transitional movement of the carrier between a transition position and the second position, wherein the transition position is located intermediate the first and second position.
Patent AU-2005266543-A1 (AU)
Title: Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Inventor: COLOTTA FRANCESCO
IPC: C07K14/705
Filed: 2005-07-21
Abstract: The invention refers to tumor-homing cells expressing the tumor necrosis factor-related apoptosis inducing ligand (TRIAL), particularly to CD34+ and NK cells transduced with adenoviral vectors coding for TRIAL. The cells of the invention are useful for the intravenous treatment of tumors, particularly of lymphoma.
Patent AU-2005282684-A1 (AU)
Title: Methods of activating NKT cells
Inventor: SAVAGE PAUL
IPC: A61K31/7032
Filed: 2005-09-02
Abstract: Provided are methods of activating an NKT cell which include a step of contacting the NKT cell with a sufficient amount of isoglobotrihexosylceramide (iGb3) to induce secretion of a cytokine from the NKT cell, stimulate proliferation of the NKT cell or upregulate expression of a cell surface marker on the NKT cell. Methods of activating an NKT cell population in a subject are also provided.
Patent AU-2005322468-A1 (AU)
Title: Apparatus and system having dry gene silencing compositions
Inventor: KHVOROVA ANASTASIA
IPC: C12N15/87
Filed: 2005-11-21
Abstract: A reverse transfection apparatus can be used for introducing siRNA into a cell to effect gene silencing. Such an apparatus can include a well plate having a well configured for transfecting cells. The well can include a substantially dry gene silencing composition that has at least a first siRNA which silences a first target gene. The gene silencing composition can be configured such that the at least first siRNA is capable of being solubilized or suspended in an aqueous medium in an amount sufficient for transfecting cells in the well. Additionally, the at least first siRNA can include a modification or a conjugate. The reverse transfection apparatus can be provided as a kit or system that additionally includes cells, polynucleotide carriers, reverse transfection reagents, and the like.
Patent WO-2007065206-A1 (WO)
Title: Selection markers for net feed intake
Inventor: HAYES BEN
IPC: C12Q1/68
Filed: 2006-12-05
Abstract: The present invention provides single nuclear polymorphisms (SNPs) associated with net feed intake (NFI) of an animal at positions 251 of the nucleotide sequences set forth as SEQ ID NOs: 1-124, and complementary sequences and fragments of said sequences comprising the SNPs. A a plurality of the SNPs in linkage disequilibrium have been assigned chromosome coordinates on syntenous regions of the human and bovine chromosome genomes, to thereby provide contiguous chromosome segments comprising cluster groups of SNPs. The present invention also provides nucleic acids comprising the individual SNPs, clusters of SNPs, and complementary nucleic acids and hybridizing thereto, and methods of using the nucleic acids in the detection and/or selection and/or breeding of animals having improved feed conversion effiency as breeding stock or for meat production.
Patent AU-2006214234-A1 (AU)
Title: New isothiazoloquinolones and related compounds as anti-infective agents
Inventor: WANG QIUPING
IPC: C07D513/14
Filed: 2006-02-15
Abstract: The invention provides certain compounds and salts of Formula I and Formula II: which possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula I and Formula II. The variables A1, R2, R3, R5, R6, R7, A8 and R9 are defined herein. Certain compounds of Formula I and Formula II disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in animals.
Patent AU-2006312735-A1 (AU)
Title: Method for producing a hot-rolled steel strip and combined casting and rolling installation for carrying out the method
Inventor: HOHENBICHLER GERALD
IPC: B21B13/22
Filed: 2006-11-03
Abstract: A method for the production of a hot-rolled steel strip from a steel melt in a continuous manufacturing process: continuously casting a steel strand in a continuous casting mold of a continuous casting plant, roll-forming the case steel strand in a first group of roll stands into a pre-rolled hot strip, roll-forming the pre-rolled hot strip in a second group of roll stands into a hot-rolled steel strip, setting the hot strip to a rolling temperature between the first and second groups, and winding or dividing the hot-rolled steel strip; further: descaling the hot strip before temperature setting, holding the hot strip in a protective gas atmosphere during temperature setting. A combined casting and rolling plant for the method is disclosed.
Patent AU-2007238347-A1 (AU)
Title: Device for treating vertebrae, including an interspinous implant
Inventor: TAYLOR JEAN
IPC: A61B17/70
Filed: 2007-04-03
Abstract: This device (10) includes an interspinous implant (1) having a flexible structure, capable of being inserted between the spinous processes (100) of two vertebrae, the areas (Z) of these respective spinous processes (100) bearing against the implant (1) defining a longitudinal axis (L) of the implant (1). According to the invention, the device includes at least one cerclage (15) capable of being adjustably engaged around the implant (1), at a centre section (4) of this implant (1), in a plane (P) perpendicular to said longitudinal axis (L); this cerclage (15) is made of a material that is inextensible in the circumferential direction of this cerclage (15), so that it makes it possible to restrain deformation of the implant (1) at the centre section (4), within the entire said plane (P), during exertion on this centre section (4) of opposing compressive forces exerted by the spinous processes of the vertebrae during a posterior movement of the spinal column.
Patent AU-2008213050-A1 (AU)
Title: Packaged product combination
Inventor: KOHL EDWIN
IPC: A61K9/20
Filed: 2008-01-28
Abstract: The packaged product combination comprises a number of different medicaments of different shape or color. The form or color of the medicaments provides application information to the respective medicaments. The application information is a recommended dosage time in relation to meal times. A blister pack (20) is provided with multiplicity, by a foil (30) locked in each case compartment (22) for the absorption of a number of medicaments, which compartment is assigned to a certain application time of the medicaments. An independent claim is also included for a method for manufacturing and packing of a product combination, which involves utilizing a number of different medicaments of different shape or color.
Patent AU-2008219622-A1 (AU)
Title: Methods for the treatment of liver diseases using specified matrix metalloproteinase (MMP) inhibitors
Inventor: SPADA ALFRED P
IPC: A61K31/4439
Filed: 2008-02-27
Abstract: Provided herein are methods for treatment of a liver disease by administering a matrix metalloproteinase inhibitor. Also provided are methods for reducing liver damage associated with a liver disease by administering the matrix metalloproteinase inhibitor described herein. Further provided are methods for lowering an elevated level of liver enzymes by administering the matrix metalloproteinase inhibitor.
Patent AU-2008243010-A1 (AU)
Title: Pierceable cap
Inventor: DIEMERT DUSTIN
IPC: B01L3/00
Filed: 2008-04-15
Abstract: A pierceable cap (211) maybe used for containing sample specimens during storage and transport. The pierceable cap may prevent unwanted escape of sample specimen before transfer with a transfer device (25). The pierceable cap may fit over a vessel. An access port (223) in the pierceable cap may allow passage of a tip (41) of a transfer device through the pierceable cap. Multiple frangible layers maybe disposed across the access port. One or more extensions (227) proximate to a lower frangible layer (215) may rotate around one or more coupling regions (247) during insertion of the transfer device. The movement of the one or more extensions may pierce the lower frangible layer to create airways and allow air to escape from a vessel at a reduced velocity. Upper frangible layers (216) may prevent escape of materials from spaces intermediate between the lower frangible layer and the upper frangible layers.
Patent AU-2008365226-A1 (AU)
Title: Method of measuring the flux of a soil gas
Inventor: RISK DAVID A
IPC: G01N13/00
Filed: 2008-12-15
Abstract: A method for determining a flux of a gas contained in a medium through a boundary of the medium comprises 1) measuring at least twice with a probe a concentration C of the gas over a time interval Δt and 2) determining the flux of the gas using the following mathematical equation: (I) where F is the gas flux, D is the diffusivity value and ΔC is a variation in the gas concentration during the time interval Δt. The probe is placed proximate the boundary. The probe has a gas inlet, a cavity, a gas concentration sensor and a membrane. Each element is in fluid communication with each other so that the gas flows from the gas inlet through the membrane and contacts the gas concentration sensor.
Patent AU-2009322270-A1 (AU)
Title: Thieno [3, 2-c] pyridine derivatives as kinase inhibitors for use in the treatment of cancer
Inventor: MICHAELIDES MICHAEL R
IPC: A61K31/4365
Filed: 2009-12-04
Abstract: Compounds that inhibit protein kinases such as Aurora-kinases and the VEGFR and PDGFR families of kinases, with an improved safety profile due to low CYP3A4 inhibition, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
Patent AU-2010206179-A1 (AU)
Title: Medicament identification system for multi-dose injection devices
Inventor: EDWARD JANSEN PAUL
IPC: A61M5/28
Filed: 2010-01-15
Abstract: An identification system for a multi-dose pen-type injection device includes an elastic band that is associated with a specific medicament can be placed around the outside of the device to allow a user to readily identify the medicament contained within the device. Alternatively, a pocket clip with a unique structural design is used as the medicament identifier.
Patent AU-2010209843-A1 (AU)
Title: Engineering NF-YB transcription factors for enhanced drought resistance and increased yield in transgenic plants
Inventor: RESHAM KULKARNI
IPC: C07K14/415
Filed: 2010-01-25
Abstract: Polynucleotides are disclosed which are capable of enhancing yield of a plant transformed to contain such polynucleotides. Also provided are methods of using such polynucleotides and transgenic plants and agricultural products, including seeds, containing such polynucleotides as transgenes.
Patent AU-2010212995-A1 (AU)
Title: Spiroindolinone pyridine derivative
Inventor: LI CHEN
IPC: C07D471/10
Filed: 2010-02-02
Abstract: There are provided compounds of the formula (I) or a pharmaceutically acceptable salt, ester or enantiomer thereof, wherein W, X, Y, V, R and R are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.
Patent AU-2010213743-A1 (AU)
Title: Sodium nitrite-containing pharmaceutical compositions
Inventor: CRAIG SHERMAN
IPC: A61K31/21
Filed: 2010-02-11
Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
Patent AU-2010223842-A1 (AU)
Title: Method and apparatus
Inventor: JOHN JOHNSTONE STUART
IPC: G09B19/00
Filed: 2010-03-09
Abstract: A method of providing cognitive training to a user, the method including, in a processing system, presenting a cognitive task to a user, the cognitive task requiring the user to view presented information and provide at least one input response; determining the at least one input response using an input device; determining from a measuring device a measure of electrical activity in the user's brain whilst performing the cognitive task; and, determining a score based on at least one of the at least one input response and the measured electrical activity.
Patent AU-2010231171-A1 (AU)
Title: Cylinder type vacuum cleaner
Inventor: JAMES DYSON
IPC: A47L9/16
Filed: 2010-03-10
Abstract: A vacuum cleaner of the cylinder type (10) comprises a separating apparatus (12) for separating dirt from a dirt-bearing fluid flow, a chassis (34) for supporting the separating apparatus (12), and a substantially spherical rolling assembly (20) comprising a fluid inlet (220) for receiving the fluid flow from the separating apparatus (12) and a motor-driver fan unit (200) as well as a filter (204) for removing particulates from the fluid flow.
Patent AU-2010239137-A1 (AU)
Title: A method and system for controlling a device
Inventor: TAN NGUYEN HUNG
IPC: A61B5/374
Filed: 2010-04-20
Abstract: A method for controlling a device, the method including the steps of, in a processing system: receiving a signal associated with a thought pattern (100), the signal being received from a single electroencephalogram (EEG) channel, the EEG channel having sensed any one or a combination of a visual cortex, a parietal cortex, or the area in between the visual cortex and the parietal cortex, and generating a control signal based on the determined thought pattern (120), the control signal being configured to initiate control of the device.
Patent AU-2010239154-A1 (AU)
Title: Method and apparatus for isolating a target bioentity from a biological sample
Inventor: MILNE CHANDLER HOWARD
IPC: G01N33/536
Filed: 2010-04-22
Abstract: A method for isolating a target bioentity from a biological sample, comprises contacting the biological sample with a magnetically-labelled ligand having selective binding affinity for the target bioentity, or for a determinant on the target bioentity, to form a target bioentity/labelled ligand complex, locating a separation module having a defined fluid flow path in the magnetic field of a magnetic module, the magnetic module comprising an array of at least two magnets in which adjacent magnets in the array are aligned with opposing polarity; passing the biological sample through the separation module to subject the biological sample to the magnetic field while the sample is passing through the defined fluid flow path to magnetically capture the target bioentity/labelled ligand complex by arresting or hindering movement of the complex within the defined fluid flow path; removing the separation module from the magnetic field; and recovering the target bioentity/labelled ligand complex from the fluid flow path.
Patent AU-2010239303-A1 (AU)
Title: Automated skin spray and dry system
Inventor: COOPER STEVEN C
IPC: A45D24/00
Filed: 2010-04-20
Abstract: A controlled application of warm dry air is provided during and/or between applications of sprays in an automated spray system. Short multiple passes of the spray cloud over the human target are provided, each being followed by application of warmed dry air for a short drying cycle that is effectuated between the individual spray passes. When the system is implemented in a booth or enclosure, warmed dry air may be supplied into the environment so as to warm the ambient air temperature prior to spraying.
Patent AU-2010243527-A1 (AU)
Title: Composite material comprising crosslinkable resin of proteinous material
Inventor: HENDRIKUS W G VAN HERWIJNEN
IPC: C07K14/435
Filed: 2010-04-29
Abstract: The invention relates to a composite material comprising more than 50 wt% filler and resin comprising proteinous material that contains proteins or polypeptides, which are cross-linkable by enzymes, and enzymes suitable for said crosslinking. The composite material is very useful for making foundry moulds or wood panels.
Patent AU-2010247866-A1 (AU)
Title: Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions
Inventor: HOJABR ALIMI
IPC: A61K39/145
Filed: 2010-05-10
Abstract: The present invention provides methods of treating, reducing, and/or preventing the incidence of an influenza related viral infection in a patient comprising administering a therapeutically effective amount of an oxidative reductive potential (ORP) water solution. The present invention also provides methods of reducing or preventing the incidence of an influenza related viral infection in a patient associated with a medical device comprising contacting the medical device with an effective amount of an ORP water solution.
Patent AU-2010288982-A1 (AU)
Title: Method for measuring a semiconductor structure, which is a solar cell or a precursor of a solar cell
Inventor: HAUNSCHILD JONAS
IPC: G01N21/64
Filed: 2010-08-16
Abstract: The invention relates to a method for measuring a semiconductor structure, which has an emitter and a base, and which is a solar cell or a precursor of a solar cell, comprising the following steps: A) Generating luminescence radiation in the semiconductor structure, and spatially resolved measuring of the luminescence radiation emitted by the semiconductor structure, wherein a first measurement is conducted under a first measurement condition , and depending on the measurement data that are obtained at least from the first measurement, a first spatially resolved, voltage-calibrated image V(x) for a plurality of local points x of the solar cell is determined from the measurement data obtained in step A; B) Determining spatially resolved properties of the semiconductor structure with respect to the spatially resolved dark saturation current , and/or the spatially resolved emitter layer resistance ,and/or the spatially resolved, local series resistance R(x) for the plurality of local points x, depending on at least the first voltage image determined in step A. The invention is characterized in that in step A, additionally at least one second measurement is carried out under a second measurement condition which differs from the first measurement condition , and depending at least on the measurement data that are obtained in the second measurement, a second spatially resolved, voltage-calibrated image V(x) for the plurality of local points x is determined from the measurement data obtained in step A. In step A, in both measurements, the luminescence radiation is substantially generated by applying an excitation radiation in a planar manner to the semiconductor structure. The measurement conditions (a, b) of the first and second measurements differ with respect to the intensities and/or spectral compositions of the excitation radiation and/or a predetermined external voltage , which is applied to the semiconductor structure by way of electrical contacting. In addition to each measurement condition (a, b), a voltage-independent, site-independent short-circuit current density (jP,a, jP,b) of the current flowing under the respective measurement conditions in the presence of short-circuit conditions is predetermined and/or measured. In step B, the determination of the spatially resolved, electrical properties at each local point xi is carried out depending on at least the short-circuit current densities (jP,a, jP,b) and a voltage-dependent, site-dependent dark current density (jD,a(xi), jD,b(xi)) for each measurement condition, wherein the dark current densities (jD,a(xi), jD,b(xi)) are at least dependent on the voltage-independent dark saturation current density (j0(xi) and the two voltages (Va(xi), Vb(xi)) resulting from the respective voltage images for site xi.
Patent AU-2010295236-A1 (AU)
Title: A method for the N-demethylation of N-methyl heterocycles
Inventor: SCAMMELLS PETER JOHN
IPC: A61K31/485
Filed: 2010-09-16
Abstract: The present invention provides methods of N-demethylating, N-methylated heterocycles and N-methyl, N-oxide heterocycles using a transition metal with an oxidation state of zero, ferrocene or substituted derivatives thereof, or Cr .N-demethylated heterocycles prepared by the methods of the present invention are also provided.